BIOMAT Database Logo BIOMAT Database Logo

Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists. 2003

Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Endocrine Unit, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.

Gonadotropin releasing hormone (GnRH) agonist has been used worldwide for the treatment of central precocious puberty. However, the results on final adult height (FAH) are discrepant in various studies especially in girls with normal early puberty. Fourteen girls with normal early puberty who were treated with depot GnRH agonists 3.75 mg intramuscular (i.m.) monthly for a mean period of 1.5 +/- 0.4 yr were retrospectively studied. The chronological age and bone age at the beginning of treatment were 9.9 +/- 0.7 yr and 12.6 +/- 0.9 yr, respectively. When the treatment was stopped, all the girls were followed-up until they reached their final adult heights. The results showed that the mean FAH was 154.0 +/- 6.9 cm, which was not significantly different from the predicted adult height (PAH) at start of treatment, 153.1 +/- 6.2 m. All the girls were divided into 2 groups. Group A was girls who had FAH-PAH at the start of treatment > or = 1.5 cm and group B, FAH-PAH at the start of treatment < 1.5 cm. The authors found that only the duration of treatment was different between these 2 groups, 1.7 +/- 0.3 yr in group A and 1.3 +/- 0.3 yr in group B (p = 0.015). In conclusion, GnRH agonist cannot improve the final height outcome in girls with normal early puberty. However, a longer period of treatment may improve the height prognosis.

UI MeSH Term Description Entries
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D011629 Puberty, Precocious Development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations below the mean age at onset of PUBERTY in the population. This early maturation of the hypothalamic-pituitary-gonadal axis results in sexual precocity, elevated serum levels of GONADOTROPINS and GONADAL STEROID HORMONES such as ESTRADIOL and TESTOSTERONE. Familial Precocious Puberty,Idiopathic Sexual Precocity,Precocious Puberty,Precocious Puberty, Central,Precocious Puberty, Male Limited,Precocious Puberty, Male-Limited,Pubertas Praecox,Sexual Precocity,Testotoxicosis,Central Precocious Puberties,Central Precocious Puberty,Familial Precocious Puberties,Idiopathic Sexual Precocities,Male-Limited Precocious Puberties,Male-Limited Precocious Puberty,Praecox, Pubertas,Precocious Puberties,Precocious Puberties, Central,Precocious Puberties, Familial,Precocious Puberties, Male-Limited,Precocious Puberty, Familial,Precocities, Idiopathic Sexual,Precocities, Sexual,Precocity, Idiopathic Sexual,Precocity, Sexual,Puberties, Central Precocious,Puberties, Familial Precocious,Puberties, Male-Limited Precocious,Puberties, Precocious,Puberty, Central Precocious,Puberty, Familial Precocious,Puberty, Male-Limited Precocious,Sexual Precocities,Sexual Precocities, Idiopathic,Sexual Precocity, Idiopathic
D001827 Body Height The distance from the sole to the crown of the head with body standing on a flat surface and fully extended. Body Heights,Height, Body,Heights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005300 Fertility Agents, Female Compounds which increase the capacity to conceive in females. Fertility Agents, Female, Hormonal,Fertility Agents, Female, Synthetic,Infertility Agents, Female,Female Fertility Agents, Synthetic,Infertility Drugs, Female,Synthetic Female Fertility Agents,Agents, Female Fertility,Agents, Female Infertility,Drugs, Female Infertility,Female Fertility Agents,Female Infertility Agents,Female Infertility Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
February 2000, The Journal of clinical endocrinology and metabolism,
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone.
December 1995, The Journal of clinical endocrinology and metabolism,
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Which method is more effective in predicting adult height in pubertal girls treated with gonadotropin-releasing hormone agonist?
September 2023, Hormones (Athens, Greece),
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
July 2008, The Journal of clinical endocrinology and metabolism,
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Normal adult height among girls treated for central precocious puberty with gonadotropin-releasing hormone analog therapy.
April 2009, Journal of pediatric endocrinology & metabolism : JPEM,
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty.
January 2023, Frontiers in endocrinology,
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
January 2018, PloS one,
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Final adult height in short healthy children treated with growth hormone and gonadotropin-releasing hormone analogs.
January 2001, The Journal of clinical endocrinology and metabolism,
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone.
April 2006, The Journal of clinical endocrinology and metabolism,
Suttipong Wacharasindhu, and Sumarlee Srivuthana, and Suphab Aroonparkmongkol, and Vichit Supornsilchai, and Paravee Hiranrat, and Viraporn Yodvisitsak
Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
February 1999, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!